Valeant — A Case Study In Rotten Culture And Business Ethics
The latest poster child for corporate malfeasance is Valeant Pharmaceuticals International Inc. The perfect enforcement storm is lining up with Congress, the U.S. Securities and Exchange Commission, and two U.S. attorney's...To view the full article, register now.
Already a subscriber? Click here to view full article